Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, giving promising progress across a variety of medical and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, much more responsible different for therapeutic use, specifically